Cristina Llorca

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

Miguel Martín, Miguel Ángel Seguí, Antonio Antón et al. · New England Journal of Medicine · 2010 · 208 citations · Full text

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 111 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer

Miguel Martín, Álvaro Rodríguez-Lescure, Emilio Alba et al. · Breast Cancer Research and Treatment · 2009 · 81 citations

Breast Oncology, Oncology, Early Breast Cancer +7

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study

Mercedes Salgado, A. García, Elvira Buxó et al. · BMC Cancer · 2018 · 34 citations · Full text

Extragonadal Nongestational Choriocarcinoma Involving the Lung: A Report of Three Cases

Jorge Aparicio, A. Oltra, Eva Martínez-Moragón et al. · Respiration · 1996 · 24 citations

Case Records, Extragonadal Choriocarcinoma, Medicine +12